Daniele Pastori | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Family history of atrial fibrillation and risk of cardiovascular events. a multicenter prospective cohort study	CIRCULATION. ARRHYTHMIA AND ELECTROPHYSIOLOGY	2020
T2238C atrial natriuretic peptide gene variant and cardiovascular events in patients with atrial fibrillation: A substudy from the ATHERO-AF cohort	INTERNATIONAL JOURNAL OF CARDIOLOGY	2020
The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF study	EUROPEAN JOURNAL OF INTERNAL MEDICINE	2020
Hdl-mediated cholesterol efflux and plasma loading capacities are altered in subjects with metabolically-but not genetically driven non-alcoholic fatty liver disease (Nafld)	BIOMEDICINES	2020
Treatment Decision-Making of Secondary Prevention After Venous Thromboembolism: Data From the Real-Life START2-POST-VTE Register	CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS	2020
Anticoagulation in patients with advanced liver disease: an open issue	INTERNAL AND EMERGENCY MEDICINE	2020
Atrial fibrillation pattern, left atrial diameter and risk of cardiovascular events and mortality. A prospective multicenter cohort study	INTERNATIONAL JOURNAL OF CLINICAL PRACTICE	2020
Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry	INTERNATIONAL JOURNAL OF CARDIOLOGY	2020
Relation of Atrial Fibrillation to Angiographic Characteristics and Coronary Artery Disease Severity in Patients Undergoing Percutaneous Coronary Intervention	THE AMERICAN JOURNAL OF CARDIOLOGY	2020
Antiphospholipid antibodies and lower extremity peripheral artery disease: A systematic review and meta-analysis	SEMINARS IN ARTHRITIS AND RHEUMATISM	2020
Hypoalbuminemia, coagulopathy, and vascular disease in COVID-19	CIRCULATION RESEARCH	2020
Correction to: Reduced lysosomal acid lipase activity in blood and platelets Is associated with nonalcoholic fatty liver disease	CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY	2020
Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register	BMJ OPEN	2020
Nox2-mediated platelet activation by glycoprotein (GP) VI: Effect of rivaroxaban alone and in combination with aspirin	BIOCHEMICAL PHARMACOLOGY	2019
Corticosteroid use and incident myocardial infarction in adults hospitalized for community-acquired pneumonia	ANNALS OF THE AMERICAN THORACIC SOCIETY	2019
Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY	2019
Atrial high-rate episodes and risk of major adverse cardiovascular events in patients with cardiac implantable electronic devices	CLINICAL RESEARCH IN CARDIOLOGY	2019
Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review	JOURNAL OF ALZHEIMER'S DISEASE	2019
Atrial high-rate episodes and thromboembolism in patients without atrial fibrillation. the west birmingham atrial fibrillation project	INTERNATIONAL JOURNAL OF CARDIOLOGY	2019
Tailored practical management of patients with atrial fibrillation. a risk factor-based approach	FRONTIERS IN CARDIOVASCULAR MEDICINE	2019

ERC

LS4
LS4_10
LS7
LS7_10

Keywords

cardiovascular disease

anticoagulation

Novel oral anticoagulants

atrial fibrillation

atherosclerosis

NAFLD

NASH

antiphospholipid antibody syndrome

ischemic heart disease

cardiovascular risk

Thrombosis

Atherothrombosis

Progetti di Ricerca

Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.